iVEAcare
Latest round
- Series A
Last raised
- Apr 2024
Total raised
- $16M
Investors
- 3
About iVEAcare
Based in Minnesota, US, and founded in 2023 by President and Chief Executive Officer Todd Kerkow, co-founders Mudit K. Jain and Lynn Elliott, iVEAcare operates as a manufacturing company providing neuromodulation therapies for clinical needs in patients suffering from chronic diseases. iVEAcare developed and commercialized neuromodulation technology platforms to treat chronic diseases. The company creates hardware and software that allows doctors to target specific areas of the brain or spinal cord with electrical stimulation and this allows healthcare professionals to improve therapies that can be provided to a larger patient base.
Who invested in iVEAcare
3 investors across 1 round
See all investors in iVEAcare
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 12, 2024
Amount
$16M
Investors
Questions about iVEAcare
Who invested in iVEAcare?
iVEAcare has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iVEAcare raised?
iVEAcare has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did iVEAcare last raise money?
iVEAcare's most recent round on record is a Series A, in Apr 2024.
What does iVEAcare do?
Based in Minnesota, US, and founded in 2023 by President and Chief Executive Officer Todd Kerkow, co-founders Mudit K.
Where is iVEAcare headquartered?
iVEAcare is headquartered in Minneapolis, US.
Which VCs invest in companies like iVEAcare?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at iVEAcare's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like iVEAcare? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.